8-K current report · filed Sep 28, 2026

ANAVEX LIFE SCIENCES CORP. (AVXL) 8-K Current Report: September 28, 2026

Item 5.07Item 5.01AVXL overview

Short answer

ANAVEX LIFE SCIENCES CORP. (AVXL) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 5.01 (Changes in Control of Registrant). Contested director election triggered a contractual board-change control event under three incentive plans and the PFO employment agreement.

ANAVEX LIFE SCIENCES CORP. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.01 · Changes in Control of Registrant

  • Contested director election triggered a contractual board-change control event under three incentive plans and the PFO employment agreement
  • Incumbent directors fell below majority: only Dr. Ma, Dr. Donhauser and Dr. van der Velden qualified after the election
  • All outstanding unvested incentive awards immediately vested and became exercisable, including awards held by Sandra Boenisch
  • Accelerated vesting creates potential dilution and increases compensation-related obligations for shareholders
  • No known arrangements indicating a subsequent change in company ownership control

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • Shareholder vote: 54,239,204 shares represented, equal to approximately 58.51% of outstanding shares
  • All six company nominees elected, defeating PVG Asset Management’s six-person activist slate
  • Incumbent board retains control, reducing immediate governance disruption but not eliminating shareholder activism risk
  • Grant Thornton LLP ratified as independent auditor for fiscal year ending September 30, 2026, with 49,432,188 votes in favor

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ANAVEX LIFE SCIENCES CORP. 8-K filings

Get the next AVXL 8-K as it lands

Follow AVXL for push alerts, or ask the research agent what this filing means.